Andrew focuses on the life sciences and his clients ranging from start-ups to major pharmaceutical and biotech companies. His technical experience covers a range of biotechnology, pharmaceuticals, and medical devices technologies. He has also conducted patent litigation in a range of technologies, and is an expert on the complexities of FRAND.
He joined EIP after a decade in the patent group of a major international law firm. His expertise includes patent drafting and prosecution, oppositions, supplementary protection certificates and life cycle strategies. A solicitor as well as a Chartered and European patent attorney, Andrew has advised on litigious proceedings from the Patents County Court to the House of Lords, and on corporate transactions including VC investment and multi-million pound acquisitions.
Andrew has a degree in Molecular Biology from the University of Edinburgh and a master's in the Management of Intellectual Property from Queen Mary’s College, University of London.